Try our Advanced Search for more refined results

TEVA PHARMACEUTICAL INDUSTRIES, LTD. et al v. SEBELIUS et al

  1. May 14, 2014

    Judge Tosses Teva's 'Premature' Suit Over Generic Copaxone

    A Washington, D.C., federal judge on Wednesday threw out Teva Pharmaceutical Industries Ltd.'s lawsuit seeking to prevent the U.S. Food and Drug Administration from approving generic versions of Teva's multiple sclerosis drug Copaxone without requiring additional clinical data, saying the case is "premature and ill-considered."

  2. May 13, 2014

    Teva's Bid To Block Generic MS Drug Is Premature, FDA Says

    The U.S. Food and Drug Administration on Monday urged a D.C. federal judge to dismiss Teva Pharmaceutical Industries Ltd.'s suit seeking to prevent the agency from approving generic versions of Teva's multiple sclerosis drug Copaxone without requiring additional clinical data, calling the suit "premature and ill-considered."

  3. May 09, 2014

    Teva Seeks Ban On Generic MS Drug Approvals By FDA

    Teva Pharmaceutical Industries Ltd. urged a Washington, D.C., federal court on Thursday to bar the U.S. Food and Drug Administration from approving generic versions of its multiple sclerosis treatment Copaxone unless they meet more stringent clinical trial standards, claiming the cheaper alternatives might pose risks to consumers.